Variables that affect the expansion rate and rupture of abdominal aortic aneurysms.
Cronenwett
J L
JL
Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire 03756, USA.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D017544:Aortic Aneurysm, Abdominal / Q000150:complications* / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology; D001019:Aortic Rupture / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D015897:Comorbidity; D003971:Diastole; D018450:Disease Progression; D006439:Hemodynamics; D006801:Humans; D006973:Hypertension / Q000453:epidemiology; D008173:Lung Diseases, Obstructive / Q000453:epidemiology; D011433:Propranolol / Q000627:therapeutic use; D012307:Risk Factors; D012907:Smoking / Q000453:epidemiology; D013314:Stress, Mechanical; D013599:Systole; D013927:Thrombosis / Q000453:epidemiology / Q000473:pathology
D000319:Adrenergic beta-Antagonists; D011433:Propranolol